Categorie -wet- en regelgeving

bv CGR, GDPR

FDA approves first drug to treat agitation symptoms associated with dementia due to Alzheimer's disease

wet- en regelgeving

FDA approves first drug to treat agitation symptoms associated with dementia due to Alzheimer’s disease

12 mei 2023

World Pharma News

FDA Advisors Endorse Approval of First Over-the-Counter Birth Control Pill, Opill

wet- en regelgeving

FDA Advisors Endorse Approval of First Over-the-Counter Birth Control Pill, Opill

11 mei 2023

Drugs.com: Drug Information Online

AstraZeneca's Farxiga gets US FDA approval to reduce risk of CV death

wet- en regelgeving

AstraZeneca’s Farxiga gets US FDA approval to reduce risk of CV death and hospitalisation for heart failure to a broader range of patients

10 mei 2023

Pharma Biz

US FDA grants 510(k) clearance and CE Mark approval for Norlase's ECHO Green Pattern Laser

wet- en regelgeving

US FDA grants 510(k) clearance and CE Mark approval for Norlase’s ECHO Green Pattern Laser

8 mei 2023

Pharma Biz

Aptar Pharma & RDD Online to co-organize RDD Europe 2023 at Antibes (Nice)

wet- en regelgeving

Aptar Pharma & RDD Online to co-organize RDD Europe 2023 at Antibes (Nice), France from May 2 to 5, 2023

7 mei 2023

Pharma Biz

FDA Approves Lumryz for Narcolepsy

wet- en regelgeving

FDA Approves Lumryz for Narcolepsy

5 mei 2023

Drugs.com: Drug Information Online

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer